TGFB1 and liver disorder: At the same time, it has been reported that perturbation of circadian rhythmicity in HSCs correlates with fibrotic gene expression in vivo and activation of the circadian clock component REV-ERB can suppress TGF-β signaling in liver disease and may attenuate the progression of fibrosis [60].